Immix Biopharma Inc. (IMMX)
2.02
-0.04 (-1.94%)
At close: Jan 17, 2025, 3:59 PM
2.08
2.97%
After-hours Jan 17, 2025, 04:48 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -15.60M | -8.23M | -24.38M | -1.15M | -972.81K |
| Depreciation & Amortization | 5.47K | 2.13K | 2.47K | 2.32K | 1.08K |
| Stock-Based Compensation | 2.57M | 624.07K | 218.98K | n/a | n/a |
| Other Working Capital | -781.56K | -936.53K | -284.97K | 169.68K | 58.74K |
| Other Non-Cash Items | n/a | 100.00K | 118.16K | 575.00K | -84.50K |
| Deferred Income Tax | n/a | n/a | 22.85M | n/a | n/a |
| Change in Working Capital | 1.65M | 195.21K | -391.04K | 165.85K | 181.70K |
| Operating Cash Flow | -11.37M | -7.41M | -1.59M | -404.69K | -790.03K |
| Capital Expenditures | -52.09K | n/a | -802 | n/a | -7.31K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -802 | n/a | n/a |
| Investing Cash Flow | -52.09K | n/a | -802 | n/a | -7.31K |
| Debt Repayment | n/a | n/a | 200.00K | n/a | 1.05M |
| Common Stock Repurchased | n/a | -99.96K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -229.38K | -56.72K | n/a | n/a | n/a |
| Financial Cash Flow | 15.46M | 3.23M | 18.85M | n/a | 1.05M |
| Net Cash Flow | 4.07M | -4.21M | 17.25M | -342.93K | 271.69K |
| Free Cash Flow | -11.42M | -7.41M | -1.59M | -404.69K | -797.34K |